A comprehensive review of the protein subunit vaccines against COVID-19
Two years after severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), in
December 2019, the first infections were identified in Wuhan city of China. SARS-CoV-2 …
December 2019, the first infections were identified in Wuhan city of China. SARS-CoV-2 …
COVID-19 vaccine acceptance among low-and lower-middle-income countries: a rapid systematic review and meta-analysis
Widespread vaccination against COVID-19 is critical for controlling the pandemic. Despite
the development of safe and efficacious vaccinations, low-and lower-middle income …
the development of safe and efficacious vaccinations, low-and lower-middle income …
Replicating viral vector-based vaccines for COVID-19: potential avenue in vaccination arena
The “severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)” is the third member of
human coronavirus (CoV) that is held accountable for the current “coronavirus disease 2019 …
human coronavirus (CoV) that is held accountable for the current “coronavirus disease 2019 …
COVID-19 vaccines: current and future perspectives
L Soraci, F Lattanzio, G Soraci, ME Gambuzza… - Vaccines, 2022 - mdpi.com
Currently available vaccines against severe acute respiratory syndrome coronavirus-2
(SARS-CoV-2) are highly effective but not able to keep the coronavirus disease 2019 …
(SARS-CoV-2) are highly effective but not able to keep the coronavirus disease 2019 …
Recombinant vaccines in 2022: a perspective from the cell factory
MT de Pinho Favaro, J Atienza-Garriga… - Microbial cell …, 2022 - Springer
The last big outbreaks of Ebola fever in Africa, the thousands of avian influenza outbreaks
across Europe, Asia, North America and Africa, the emergence of monkeypox virus in …
across Europe, Asia, North America and Africa, the emergence of monkeypox virus in …
Perception of COVID-19 booster dose vaccine among healthcare workers in India and Saudi Arabia
S Vellappally, S Naik, O Alsadon, AA Al-Kheraif… - International journal of …, 2022 - mdpi.com
Background: COVID-19 vaccines were made available to the public by the end of 2020.
However, little is known about COVID-19 booster dose (CBD) vaccine perception among …
However, little is known about COVID-19 booster dose (CBD) vaccine perception among …
Effectiveness of vaccination against SARS-CoV-2 Omicron variant infection, symptomatic disease, and hospitalization: A systematic review and meta-analysis
A Meggiolaro, M Sane Schepisi, S Farina… - Expert Review of …, 2022 - Taylor & Francis
Background This meta-analysis aims to assess the effectiveness of the current Sars-Cov2
vaccine regimens against Omicron infection. A secondary endpoint aims to investigate the …
vaccine regimens against Omicron infection. A secondary endpoint aims to investigate the …
Planning and organization of the covid-19 vaccination campaign: An overview of eight european countries
The initial progress of the COVID-19 vaccination campaign worldwide depended on several
aspects, including programmatic/practical issues. This paper focused on the planning and …
aspects, including programmatic/practical issues. This paper focused on the planning and …
COVID-19 vaccine design and vaccination strategy for emerging variants
VP Chavda, V Apostolopoulos - Expert Review of Vaccines, 2022 - Taylor & Francis
Since the beginning of the pandemic, new 'severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2)'variants that have the ability to influence the airborne transmission, virulence …
(SARS-CoV-2)'variants that have the ability to influence the airborne transmission, virulence …
A review of inactivated COVID-19 vaccine development in China: focusing on safety and efficacy in special populations
L Hu, J Sun, Y Wang, D Tan, Z Cao, L Gao, Y Guan… - Vaccines, 2023 - mdpi.com
The coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), has been widespread globally, and …
respiratory syndrome coronavirus 2 (SARS-CoV-2), has been widespread globally, and …